Abstract: The present teachings provide a compound represented by structural formula (I): or a pharmaceutically acceptable salt thereof. Also described are pharmaceutical compositions and methods of use thereof.
Type:
Application
Filed:
June 21, 2013
Publication date:
January 2, 2014
Applicant:
UNIVERSITY HEALTH NETWORKS
Inventors:
Heinz W. Pauls, Radoslaw Laufer, Sze-Wan Li, Grace Ng
Abstract: The invention is directed to a compound represented by the following structural formula and pharmaceutically acceptable salts thereof: Compounds represented by this structural formula are kinase inhibitors and are therefore disclosed herein for the treatment of cancer. Definitions for the variables in the structural formula are provided herein.
Type:
Application
Filed:
June 21, 2012
Publication date:
October 18, 2012
Applicant:
UNIVERSITY HEALTH NETWORKS
Inventors:
Peter Brent SAMPSON, Yong LIU, Sze-Wan LI, Bryan T. FORREST, Heinz W. PAULS, Louise G. EDWARDS, Miklos FEHER, Narendra Kumar B. PATEL, Radoslaw LAUFER, Guohua PAN
Abstract: The invention is directed to a compound represented by the following structural formula and pharmaceutically acceptable salts thereof: Compounds represented by this structural formula are kinase inhibitors and are therefore disclosed herein for the treatment of cancer. Definitions for the variables in the structural formula are provided herein.
Type:
Application
Filed:
April 6, 2011
Publication date:
October 27, 2011
Applicant:
UNIVERSITY HEALTH NETWORKS
Inventors:
Peter B. Sampson, Yong Liu, Sze-Wan Li, Bryan T. Forrest, Heinz W. Pauls, Louise G. Edwards, Miklos Feher, Narendra Kumar B. Patel, Radoslaw Laufer, Guohua Pan